The UroLift® System treatment is a revolutionary, minimally invasive approach to treating an enlarged prostate, or BPH, that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.
Clinical data has shown that the UroLift System treatment is safe and effective in relieving lower urinary tract symptoms due to BPH without compromising sexual function1,4. The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities.
Most common side effects are light blood in the urine, some pain or discomfort when urinating, some increased urge to go and discomfort in the pelvis that typically resolve within two to four weeks after the procedure.
Rapid symptom relief, better than reported for medications2
Risk profile better than reported for surgical procedures such as TURP3
Preservation of sexual function1
Return to normal activity in days not months
Increased quality of life
No ongoing BPH medications
19 clinical study publications; 4 years published clinical data4
An enlarged prostate compresses on the urethra, making it difficult for urine to flow.
The UroLift Device is placed through the obstructed urethra to access the enlarged prostate.
Small UroLift Implants are permanently placed to lift and hold the enlarged prostate tissues out of the way and increase the opening of the urethra. The permanent implants are delivered through a small needle that comes out of the UroLift delivery device and into the prostate.
The UroLift delivery device s removed, leaving an open urethra designed to provide symptom relief.